TMCnet News
Global Cancer Monoclonal Antibodies Market - Growth, Trend & Forecast (2015-2020) - High Cost for Research & Development - Research and MarketsResearch and Markets has announced the addition of the "Global Cancer Monoclonal Antibodies Market - Growth, trend, and forecast (2015-2020)" report to their offering. The Global Cancer Monoclonal Antibodies Market was valued at USD 27 billion for the year 2015, and is expected to grow at a CAGR of around 8-15% from 2015 to 2020. Cancer is a severe disease, which starts from a single cell; cancer genetically transforms a normal cell into a tumor cell. Gradually, it spreads to more cells. There is no one definite cause for cancer. The interaction between a person's genetic factor and other external agents (physical carcinogens, such as ultraviolet and ionizing radiation, chemical carcinogens, and biological carcinogens) can roughly be cited as the major cause. Drugs haven't been able to provide complete cure for any cancer. Moreover, all these drugs available for cancer as chemotherapeutic agents have adverse side-effects because the drugs tend to affect the normal, healthy cells along with the cancerous cells. Henc, there is huge amount of research and development going on all over the world to combat this deadly disease. Drivers:
Challenges:
Companies Mentioned:
Key Topics Covered: 1. Introduction 2. Research Methodology 3. Executive Summary 4. Key Inferences 5. Market Overview and Industry trends 6. Drivers, Restraints, Opportunities 7. Market Segmentation 8. Market segmentation by Geography - Regional Share and forecast 9. Competitive Landscape 10. Key Vendor Analysis 11. Analyst outlook for Investment opportunities 12. Future Outlook of the market For more information visit http://www.researchandmarkets.com/research/cvrndr/global_cancer View source version on businesswire.com: http://www.businesswire.com/news/home/20160722005741/en/ |
